60 results
8-K
EX-99.1
VNDA
Vanda Pharmaceuticals Inc
28 Oct 20
Vanda Pharmaceuticals Reports Third Quarter 2020 Financial Results
4:05pm
(ODYSSEY VLY-686-3501) shows that tradipitant may accelerate clinical improvement in patients with COVID-19 pneumonia.1 Vanda continues to recruit
424B5
uk9q9
22 Dec 14
Prospectus supplement for primary offering
12:00am
424B5
y6t8 06st6t
29 Oct 14
Prospectus supplement for primary offering
12:00am
424B5
j1p5iv
28 Oct 14
Prospectus supplement for primary offering
12:00am